Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action

NCT01293292 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Teriparatide

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust